Literature DB >> 20397950

The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity.

Linda-Gail Bekker1, Robin Wood.   

Abstract

Tuberculosis (TB) has proven to be difficult to control in regions with a high prevalence of human immunodeficiency virus (HIV) infection. We previously described high prevalence of HIV infection among adults (23%) and rapidly escalating TB notification rates in a peri-urban township, Site-M in Cape Town, South Africa. The combination of delineated boundaries, a well-characterized population, centralized TB record keeping, and high levels of HIV testing make this population uniquely suited for TB epidemiologic and transmission studies. The driver of the HIV and TB coepidemic appears to be a high annual risk of Mycobacterium tuberculosis infection in this community. A high annual risk of M. tuberculosis infection may be the result of unrecognized infections coupled with intense social interaction and crowding. New non-facility-based interventions will be required, with emphasis on community-based case finding and contact tracing to decrease the infective TB pool. There is a need for better understanding of the transmission dynamics of TB and the intensity of social interactions, which have exacerbated an HIV and TB epidemic in this community of hyperendemicity.

Entities:  

Mesh:

Year:  2010        PMID: 20397950     DOI: 10.1086/651493

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Authors:  David W Dowdy; Jonathan E Golub; Valeria Saraceni; Lawrence H Moulton; Solange C Cavalcante; Silvia Cohn; Antonio G Pacheco; Richard E Chaisson; Betina Durovni
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

2.  Longitudinal assessment of health related quality of life of HIV infected patients treated for tuberculosis and HIV in a high burden setting.

Authors:  Thuli Mthiyane; Alex Pym; Keertan Dheda; Roxana Rustomjee; T Reddy; Shamila Manie
Journal:  Qual Life Res       Date:  2016-06-09       Impact factor: 4.147

3.  The Risk of Tuberculosis among Populations Living in Slum Settings: a Systematic Review and Meta-analysis.

Authors:  Ekaterina Noykhovich; Sangeeta Mookherji; Amira Roess
Journal:  J Urban Health       Date:  2019-04       Impact factor: 3.671

4.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

Review 5.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 6.  Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease.

Authors:  Brian Henderson; Andrew Martin
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 7.  A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.

Authors:  Anushka Naidoo; Kogieleum Naidoo; Helen McIlleron; Sabiha Essack; Nesri Padayatchi
Journal:  J Clin Pharmacol       Date:  2017-07-24       Impact factor: 3.126

8.  The hidden harm of home-based care: pulmonary tuberculosis symptoms among children providing home medical care to HIV/AIDS-affected adults in South Africa.

Authors:  Lucie Cluver; Mark Orkin; Mosa Moshabela; Caroline Kuo; Mark Boyes
Journal:  AIDS Care       Date:  2013-03-04

9.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.

Authors:  Chuan-Chin Huang; Eric Tchetgen Tchetgen; Mercedes C Becerra; Ted Cohen; Katherine C Hughes; Zibiao Zhang; Roger Calderon; Rosa Yataco; Carmen Contreras; Jerome Galea; Leonid Lecca; Megan Murray
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

10.  Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

Authors:  Tandakha N Dieye; Birahim P Ndiaye; Alle B Dieng; Marema Fall; Nathaniel Brittain; Nathaniel Britain; Samantha Vermaak; Makhtar Camara; Halimatou Diop-Ndiaye; Ndeye Fatou Ngom-Gueye; Papa A Diaw; Coumba Toure-Kane; Papa S Sow; Souleymane Mboup; Helen McShane
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.